Subgroup analysis for progestin (RR 0.17, 95% CI: 0.02 to 1.36, 1 study, 32 patients) and GnRH agonist studies (RR 0.62, 95% CI: 0.35 to 1.13, 7 studies, 929 patients, I 2 = 52%, random effects model) showed a trend towards a decrease in endometriosis recurrence; however, statistical significance was not reached.
← all excerpts
Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis.
1
—
—